PA 2120 (Valproic Acid 250 mg)

Pill with imprint PA 2120 is White, Capsule-shape and has been identified as Valproic Acid 250 mg. It is supplied by Teva Pharmaceuticals USA.

Valproic acid is used in the treatment of epilepsy; schizoaffective disorder; seizure prevention; seizures; mania and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PA 2120

Valproic Acid

Imprint: PA 2120
Strength: 250 mg
Color: White
Size: 19.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk - When treating epilepsy, X - Not for use in pregnancy - When treating migraine
CSA Schedule: Not a controlled drug
Labeler / Supplier: Teva Pharmaceuticals USA
National Drug Code (NDC): 50111-0852
Inactive Ingredients: corn oil, FD&C Blue No. 1, gelatin, glycerin, water, titanium dioxide
Note: Inactive ingredients may vary.